Multimedia

Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?

Author and Disclosure Information

Psoriasis patients are reaching out to their dermatologists with concerns about taking biologics and the risk for coronavirus disease 2019 (COVID-19). Dr. Lawrence Green provides his recommendation, which is for patients to continue their biologics. "If you stop your biologic, and it will take a few months for your psoriasis to come back, but when that happens, if you go back to where you were you're at much more risk for COVID-19 infection than you are right now taking your biologic and controlling your disease," he reports. If patients have had exposure to COVID-19 or develop symptoms, they should stop biologics immediately. Patients taking biologics should exercise extra precautions, as recommended by the Centers for Disease Control and Prevention, to prevent infection.


 

Vidyard Video

Recommended Reading

Emergency Rule: Docs can bill for telehealth and COVID-19 tests. Here’s how
MDedge Neurology
Preventable diseases could gain a foothold because of COVID-19
MDedge Neurology
Should patients with COVID-19 avoid ibuprofen or RAAS antagonists?
MDedge Neurology
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
MDedge Neurology
Amid hydroxychloroquine hopes, lupus patients face shortages
MDedge Neurology